Results 171 to 180 of about 1,358,072 (286)
The pivotal role of software defined networks to safeguard against cyber attacks: a comprehensive review. [PDF]
Aljughaiman A, Almarri S.
europepmc +1 more source
Control and Management Plane in a Multi-stage Software Router Architecture [PDF]
Bianco, Andrea +7 more
core +2 more sources
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo +19 more
wiley +1 more source
Cross-Domain Communication Method Based on Load Balancing for SDNs. [PDF]
Wang X, Zhou Y, Dan F, Yang X.
europepmc +1 more source
Cognitive Behavioral Therapy for Youth with Childhood‐Onset Lupus: A Randomized Clinical Trial
Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham +29 more
wiley +1 more source
AI-driven routing pipeline in software-defined networks using DQL: a mini review. [PDF]
Goteti D, Reddy VK.
europepmc +1 more source
Objective We developed a novel EHR sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk +16 more
wiley +1 more source
Construction of a user-friendly software-defined networking management using a graph-based abstraction layer. [PDF]
Jia Y, Ren J, Li X, He H, Zhang P, Li R.
europepmc +1 more source
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie +3 more
wiley +1 more source
Rethinking max-min planning on energy-efficient software-defined networking for 5G networks. [PDF]
Jiang D +6 more
europepmc +1 more source

